Published in Int J Oncol on April 02, 2013
Down-regulation of mir-221 and mir-222 restrain prostate cancer cell proliferation and migration that is partly mediated by activation of SIRT1. PLoS One (2014) 1.06
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells. PLoS One (2014) 1.01
MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology. Int J Endocrinol (2014) 0.93
Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis. Am J Transl Res (2014) 0.88
MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer. Clin Exp Metastasis (2015) 0.86
Cancer stem cells as a potential therapeutic target in thyroid carcinoma. Oncol Lett (2016) 0.77
Secreted uPAR isoform 2 (uPAR7b) is a novel direct target of miR-221. Oncotarget (2015) 0.77
MiR-186 Inhibited Migration of NSCLC via Targeting cdc42 and Effecting EMT Process. Mol Cells (2017) 0.75
Downregulation of miR-221/222 by a microRNA sponge promotes apoptosis in oral squamous cell carcinoma cells through upregulation of PTEN. Oncol Lett (2016) 0.75
miR-219-5p inhibits proliferation and clonogenicity in chordoma cells and is associated with tumor recurrence. Oncol Lett (2016) 0.75
MicroRNA Expression in a Readily Accessible Common Hepatic Artery Lymph Node Predicts Time to Pancreatic Cancer Recurrence Postresection. J Gastrointest Surg (2016) 0.75
MicroRNAs as Biomarkers in Thyroid Carcinoma. Int J Genomics (2017) 0.75
MicroRNA-92a promotes cell viability and invasion in cervical cancer via directly targeting Dickkopf-related protein 3. Exp Ther Med (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
MicroRNA gene expression deregulation in human breast cancer. Cancer Res (2005) 27.56
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med (2005) 26.02
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell (2006) 23.59
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature (2007) 21.53
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res (2005) 10.46
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA (2007) 9.97
The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A (2005) 8.60
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med (1994) 8.39
Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res (2004) 7.96
Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun (2005) 7.50
Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol (2002) 7.17
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene (2006) 6.61
Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J (2007) 6.26
Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res (1999) 5.69
MicroRNAs as oncogenes and tumor suppressors. N Engl J Med (2005) 5.67
Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA (2007) 5.35
Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am J Pathol (2004) 5.29
miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem (2007) 5.02
MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem (2008) 4.56
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev (2009) 4.15
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene (2008) 4.11
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer (2007) 3.53
MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab (2008) 3.40
MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer (2009) 2.57
Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer Sci (2008) 2.39
Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet (2008) 2.03
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol (2008) 2.03
Use of Bordetella pertussis BP3385 to establish a cutoff value for an IS481-targeted real-time PCR assay. J Clin Microbiol (2008) 1.88
MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer (2009) 1.87
Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res (2008) 1.72
MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res (2011) 1.48
A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer (2001) 1.36
microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J Biol Chem (2010) 1.27
MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med Oncol (2009) 1.26
Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples. Thyroid (2011) 1.18
Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Endocr Relat Cancer (2010) 1.16
Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery (1992) 1.10
Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol (2011) 1.04
Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Ann Surg (2009) 1.03
Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination. World J Surg (2007) 1.03
Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid (2011) 1.00
Global changes of mRNA expression reveals an increased activity of the interferon-induced signal transducer and activator of transcription (STAT) pathway by repression of miR-221/222 in glioblastoma U251 cells. Int J Oncol (2010) 0.90
High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas. Br J Cancer (2004) 0.88
A PCR-based expression signature of malignancy in follicular thyroid tumors. Endocr Relat Cancer (2007) 0.84
An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid (2003) 3.23
An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg (2010) 2.81
Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy. World J Surg (2010) 2.75
Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid (2013) 2.66
Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement. Laryngoscope (2011) 2.55
Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod (2009) 2.17
Surgical complications of posterior lumbar interbody fusion with total facetectomy in 251 patients. J Neurosurg Spine (2006) 2.11
BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients. Endocr J (2008) 2.06
Trial of autotransplantation of cryopreserved thyroid tissue for postoperative hypothyroidism in patients with Graves' disease. J Am Coll Surg (2002) 2.04
Global oxygen detection in water using luminescent probe on anodized aluminum. Sensors (Basel) (2009) 1.99
Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One (2011) 1.98
Four cases of Graves' disease which developed after painful Hashimoto's thyroiditis. Intern Med (2006) 1.90
Irradiation prolongs survival of Alport mice. J Am Soc Nephrol (2008) 1.84
Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma; difference in clinicopathological features of FAP-associated and sporadic patients. Endocr J (2011) 1.72
A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells. Cancer Res (2004) 1.67
Risk factors for adjacent segment degeneration after PLIF. Spine (Phila Pa 1976) (2004) 1.65
Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg (2005) 1.63
Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg (2006) 1.63
Pulmonary injury after cardiopulmonary bypass: beneficial effects of low-frequency mechanical ventilation. J Thorac Cardiovasc Surg (2009) 1.60
Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg (2007) 1.58
RT-PCR-based analysis of microRNA (miR-1 and -124) expression in mouse CNS. Brain Res (2006) 1.55
Surgical strategy for cervical myelopathy due to ossification of the posterior longitudinal ligament: Part 2: Advantages of anterior decompression and fusion over laminoplasty. Spine (Phila Pa 1976) (2007) 1.54
Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J (2008) 1.53
Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J (2006) 1.49
Ovarian endometriosis showing decidual change and Arias-Stella reaction with biotin-containing intranuclear inclusions. Acta Cytol (2003) 1.49
Thyrotoxicosis caused by weight-reducing herbal medicines. Arch Intern Med (2005) 1.49
Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab (2007) 1.49
Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid (2009) 1.48
Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease. Clin Endocrinol (Oxf) (2009) 1.47
Effect of platelet-rich plasma with fibrin matrix on healing of intrasynovial flexor tendons. J Hand Surg Am (2012) 1.47
Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg (2012) 1.47
Serum concentrations of granulocyte colony-stimulating factor (G-CSF) in antithyroid drug-induced agranulocytosis. Endocr J (2004) 1.46
Surgical strategy for cervical myelopathy due to ossification of the posterior longitudinal ligament: Part 1: Clinical results and limitations of laminoplasty. Spine (Phila Pa 1976) (2007) 1.46
Mutational analysis of the APC gene in cribriform-morula variant of papillary thyroid carcinoma. World J Surg (2006) 1.46
MicroRNA (miRNA) cloning analysis reveals sex differences in miRNA expression profiles between adult mouse testis and ovary. Reproduction (2008) 1.44
Map-guided surgery for atrial fibrillation. J Thorac Cardiovasc Surg (2005) 1.44
Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J Surg (2012) 1.43
Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective study. Int J Urol (2013) 1.41
Transient hyperthyroidism after withdrawal of antithyroid drugs in patients with Graves' disease. Endocr J (2004) 1.41
Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res (2008) 1.40
External branch of the superior laryngeal nerve monitoring during thyroid and parathyroid surgery: International Neural Monitoring Study Group standards guideline statement. Laryngoscope (2013) 1.40
Ernest L. Mazzaferri, MD, MACP (1936-2013). Thyroid (2013) 1.39
Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg (2006) 1.39
CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1. FEBS Lett (2006) 1.38
A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab (2007) 1.35
Distinct clinical, serological, and sonographic characteristics of hashimoto's thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab (2010) 1.34
Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1. J Clin Invest (2002) 1.34
Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. Thyroid (2011) 1.34
Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg (2006) 1.32
Recovery of parathyroid function after total thyroidectomy: long-term follow-up study. ANZ J Surg (2005) 1.30
Hypofractionated radiotherapy with carbon ion beams for prostate cancer. Int J Radiat Oncol Biol Phys (2005) 1.29
Surgical outcomes of posterior lumbar interbody fusion in elderly patients. J Bone Joint Surg Am (2006) 1.29
Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg (2004) 1.26
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4-ALK-rearranged non-small-cell lung cancer harbored coexisting EGFR mutation. BMC Cancer (2013) 1.26
Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg (2005) 1.25
Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg (2004) 1.24
Fucoxanthin induces cell cycle arrest at G0/G1 phase in human colon carcinoma cells through up-regulation of p21WAF1/Cip1. Biochim Biophys Acta (2005) 1.23
Establishment of an intraoperative staging system (iStage) by improving UICC TNM classification system for papillary thyroid carcinoma. World J Surg (2010) 1.22
Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy. Laryngoscope (2007) 1.22
Desmoplastic small round cell tumor: imaging findings associated with clinicopathologic features. J Comput Assist Tomogr (2002) 1.22
The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J Med Genet (2011) 1.20
Sequencing and bioinformatics-based analyses of the microRNA transcriptome in hepatitis B-related hepatocellular carcinoma. PLoS One (2011) 1.19
Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. Endocr J (2009) 1.19
Hydroxysteroid (17-β) dehydrogenase 1 is dysregulated by miR-210 and miR-518c that are aberrantly expressed in preeclamptic placentas: a novel marker for predicting preeclampsia. Hypertension (2011) 1.19
Tumor thrombus of thyroid malignancies in veins: importance of detection by ultrasonography. Thyroid (2011) 1.18
Clinicopathologic significance of intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation: a collaborative study with Member Institutes of The Japanese Society of Thyroid Surgery. Am J Clin Pathol (2007) 1.18
MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs. J Nippon Med Sch (2009) 1.18
Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med (2008) 1.18
Autonomic dysreflexia associated with Charcot spine following spinal cord injury: a case report and literature review. Eur Spine J (2010) 1.17
Gastric inverted hyperplastic polyp. Report of four cases and relation to gastritis cystica profunda. APMIS (2002) 1.17
Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan. J Clin Endocrinol Metab (2013) 1.16
Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma. Thyroid (2010) 1.15
Biological behavior and prognosis of familial papillary thyroid carcinoma. Surgery (2008) 1.15
Current advancement in radiation therapy for uterine cervical cancer. J Radiat Res (2010) 1.14
Menstrual disturbances in various thyroid diseases. Endocr J (2010) 1.14
Serial changes in liver function tests in patients with thyrotoxicosis induced by Graves' disease and painless thyroiditis. Thyroid (2008) 1.13
Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma. Int J Oncol (2009) 1.13
Haplotype analysis reveals founder effects of thyroglobulin gene mutations C1058R and C1977S in Japan. J Clin Endocrinol Metab (2006) 1.12
Choriocarcinoma of the lung: report of a case. Gen Thorac Cardiovasc Surg (2012) 1.11
Characterization and optimization of polymer-ceramic pressure-sensitive paint by controlling polymer content. Sensors (Basel) (2011) 1.11
Distinct histopathological features of Hashimoto's thyroiditis with respect to IgG4-related disease. Mod Pathol (2012) 1.11
Acral myxoinflammatory fibroblastic sarcoma: a report of five cases and review of the literature. Virchows Arch (2002) 1.10
Colonic pseudolipomatosis, microscopically classified into two groups. J Gastroenterol Hepatol (2006) 1.07
Acute suppurative thyroiditis after fine-needle aspiration causing thyrotoxicosis. Thyroid (2005) 1.07
A novel protein C-phycocyanin plays a crucial role in the hypocholesterolemic action of Spirulina platensis concentrate in rats. J Nutr (2005) 1.07
Decreased expression of tumor protein p53-induced nuclear protein 1 (TP53INP1) in breast carcinoma. Anticancer Res (2007) 1.05
Ultrasonographic evaluation of thyroid nodules in 900 patients: comparison among ultrasonographic, cytological, and histological findings. Thyroid (2007) 1.05
Independent involvement of CD8+ CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto's disease. Thyroid (2002) 1.05
Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene. J Pathol (2003) 1.05
[Difficult tracheal intubation using airway scope in a pediatric patient with Hunter syndrome]. Masui (2009) 1.04